Definitive Healthcare Corp.
General ticker "DH" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $272.9M (TTM average)
Definitive Healthcare Corp. does not follow the US Stock Market performance with the rate: -23.5%.
Estimated limits based on current volatility of 7.8%: low 0.92$, high 1.07$
Factors to consider:
- Total employees count: 686 (-12.3%) as of 2025
- US accounted for 95.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market competition, Data accuracy risks, Innovation failure, Customer churn, Macro instability
- Current price 47.1% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.96$, 4.32$]
- 2026-12-31 to 2027-12-31 estimated range: [1.97$, 4.30$]
Financial Metrics affecting the DH estimates:
- Positive: with PPE of 10.7 at the end of fiscal year the price was very low
- Negative: negative Operating income
- Positive: Operating cash flow per share per price, % of 18.91 > 13.08
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 54.09 > -0.64
- Positive: 42.26 < Shareholder equity ratio, % of 51.53 <= 63.63
- Positive: Inventory ratio change, % of -1.64 <= -0.75
- Negative: Industry earnings per price (median), % of 0 <= 0
Short-term DH quotes
Long-term DH plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $251.41MM | $252.20MM | $241.52MM |
| Operating Expenses | $581.22MM | $963.02MM | $465.79MM |
| Operating Income | $-329.80MM | $-710.82MM | $-224.27MM |
| Non-Operating Income | $21.62MM | $77.08MM | $15.02MM |
| Interest Expense | $15.20MM | $14.84MM | $11.29MM |
| R&D Expense | $42.44MM | $36.52MM | $34.78MM |
| Income(Loss) | $-308.18MM | $-633.75MM | $-209.26MM |
| Taxes | $-18.55MM | $-42.30MM | $-9.96MM |
| Net Income(Loss)* | $-202.39MM | $-413.12MM | $-138.93MM |
| Stockholders Equity | $1,199.17MM | $607.19MM | $378.99MM |
| Assets | $1,825.90MM | $1,089.39MM | $735.49MM |
| Operating Cash Flow | $41.19MM | $58.20MM | $53.78MM |
| Capital expenditure | $2.98MM | $12.34MM | $16.72MM |
| Investing Cash Flow | $-31.78MM | $-26.41MM | $153.88MM |
| Financing Cash Flow | $-25.58MM | $-56.75MM | $-150.79MM |
| Earnings Per Share** | $-1.79 | $-3.54 | $-1.30 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.